- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis
This is a Virtual Event for PsychU members in the San Diego, Imperial, Riverside, San Bernardino, Long Beach, Los Angeles, and Bakersfield Counties, CA.
In this presentation, the objectives are to:
- Provide a brief overview of depression prevalence and current standard treatments
- Review the monoamine hypothesis of depression
- Discuss alternative hypotheses of depression
- Highlight potential new therapeutic intervention targets

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Elika Hefazi, PharmD, BCPP
Medical Science Liaison
Speakers Sucharita Somkuwar, PhD, BPharm and Elika Hefazi, PharmD, BCPP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.